MARAVAI LIFESCIENCES HOLDINGS INC
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our corporate headquarters and certain of our research and development operations are located in San Diego, California. The facilities serve as the principal hub of operations for our nucleic acid production business and were purpose built to expand the capacity of this business segment while adding specialized capabilities in the form of clean rooms, air handling, waste and solvent handling, and GMP capabilities. Our facility leases expire at varying dates through 2038, not including renewals that are at our option.
All facilities are leased. A summary of our facilities is listed below.
| Location | Approx. Square Footage | Segment |
|---|---|---|
| San Diego, CA | 237,000 | Nucleic Acid Production |
| Sterling, VA | 21,000 | Nucleic Acid Production |
| Leland, NC | 46,000 | Biologics Safety Testing |
| Southport, NC | 20,000 | Biologics Safety Testing |
| Jupiter, FL | 17,000 | Nucleic Acid Production |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.